25 molecular-modeling-or-molecular-dynamic-simulation Fellowship positions at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
for precision targeting of AML, an aggressive leukaemia with poor survival outcomes. Building on strong preliminary data, it combines mechanistic and translational immunology with bespoke in vivo models to define
-
. As an essential part of the project team, you will work on: Designing and testing novel metamaterial unit cells tailored for transformer enclosures. Numerical modelling using advanced FEM/BEM
-
tailored for transformer enclosures. Numerical modelling using advanced FEM/BEM techniques to evaluate vibro-acoustic performance. Experimental field/laboratory testing of large-scale prototypes in real
-
learning, the topology and geometry of data, or the dynamics of learning. The successful candidate should have, or be expecting soon to receive, a PhD in Mathematics, or related field, with demonstrated
-
. The project seeks to develop mathematical models for allocation of critical resources during pandemics. Populating these instances with real-world data we would then develop novel algorithms to solve them
-
this will involve the development of novel ML/DL methods which leverage both computational and experimental data. Candidates should also have experience of numerical modelling (e.g. CFD and FEA), working as
-
, German Research Foundation. The selected candidate would conduct research at the interface of theory and application. The project seeks to develop mathematical models for allocation of critical resources
-
to gender—and demonstrated expertise in advanced statistical methods (e.g., multilevel modelling). The successful candidate will work closely with the Principal Investigator, Dr. Verena Klein, a PhD student
-
and environment can be part of the role, including performing in vitro and, where necessary, in vivo (animal models) studies in preparation of potential first-human studies. For this purpose, there will
-
(animal models) studies in preparation of potential first-human studies. For this purpose, there will be a tight interaction between the Cancer B-cell group and Prof. Mark Cragg at the Antibody Vaccine